Clinical Trials Directory

Trials / Completed

CompletedNCT04186338

Daily Physical Activity in Myelomeningocele

Daily Physical Activity in Children and Adolescents With Low Lumbar and Sacral Level Myelomeningocele

Status
Completed
Phase
Study type
Observational
Enrollment
20 (actual)
Sponsor
Marmara University · Academic / Other
Sex
All
Age
6 Years – 16 Years
Healthy volunteers
Accepted

Summary

Obesity is getting more common and challenging to treat in children and adolescents with myelomeningocele. Therefore, it is becoming more important to determine daily physical activity in these patients. Daily walking performance and average steps per day in patients with low lumbar and sacral level myelomeningocele are shown to not differ from healthy controls. Step counts can not reflect all torsional accelerations associated with daily living activities. Omnidirectional accelerometers provide all types of body movement outputs and give detailed parameters of physical activity level and energy expenditure. There is no data about energy expenditure and physical activity level of the patients with myelomeningocele in daily routine. This study aims to quantify energy expenditure and physical activity of children and adolescents with low lumbar and sacral level myelomeningocele.

Detailed description

Children and adolescents with low lumbar and sacral level myelomeningocele, and age-, sex-, and BMI-matched controls were included. Omnidirectional accelerometer monitor (Actical®) was used to assess activity energy expenditure and daily durations spent in sedentary, light activity and moderate to vigorous physical activity (MVPA).

Conditions

Interventions

TypeNameDescription
DEVICEOmnidirectional accelerometer monitor (3x3 cm and 16 g, Actical®, Philips Respironics)All participants were instructed to wear monitors for five consecutive days except during water-based activities. Data for each participant was collected to ensure included three valid weekdays. Daily activity energy expenditure (kcal/kg/min), and sedentary, light, moderate and vigorous levels (min) were examined using a software program.

Timeline

Start date
2016-12-01
Primary completion
2017-04-01
Completion
2017-05-01
First posted
2019-12-04
Last updated
2019-12-06

Source: ClinicalTrials.gov record NCT04186338. Inclusion in this directory is not an endorsement.